Immunogenicity of HIV-1-Based Virus-Like Particles with Increased Incorporation and Stability of Membrane-Bound Env

An optimal prophylactic vaccine to prevent human immunodeficiency virus (HIV-1) transmission should elicit protective antibody responses against the HIV-1 envelope glycoprotein (Env). Replication-incompetent HIV-1 virus-like particles (VLPs) offer the opportunity to present virion-associated Env wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonelli, Christopher A., King, Hannah A. D., Mackenzie, Charlene, Sonza, Secondo, Center, Rob J., Purcell, Damian F. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002006/
https://www.ncbi.nlm.nih.gov/pubmed/33801906
http://dx.doi.org/10.3390/vaccines9030239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002006/
https://www.ncbi.nlm.nih.gov/pubmed/33801906
http://dx.doi.org/10.3390/vaccines9030239

Ejemplares similares